Arbutus Biopharma Corporation (ABUS) revenue

Revenue · fiscal 2025
$14.08M

Arbutus Biopharma Corporation (ABUS) reported revenue of $14.08M in fiscal 2025 (the year ended December 31, 2025). That is 128.2% higher than the $6.17M of fiscal 2024. Figures as of 18 Nov 2026, 12:06 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$14.08M
Change on fiscal 2024
+128.2%
Growth, 5 years
+15.3% a year
Growth, 10 years
−4.9% a year
Highest on record
$39.02Mfiscal 2022
Lowest on record
$1.49Mfiscal 2016
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Arbutus Biopharma Corporation revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 15.3% a year; over ten years the rate was −4.9% a year. Across the 15 fiscal years on record (2011–2025), the highest was $39.02M in fiscal 2022 and the lowest $1.49M in fiscal 2016.

History · 15 fiscal years

Revenue by fiscal year

Arbutus Biopharma Corporation revenue, year by year

Arbutus Biopharma Corporation (ABUS) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$14.08M 128.2% up
2024$6.17M 66.0% down
2023$18.14M 53.5% down
2022$39.02M 255.1% up
2021$10.99M 58.9% up
2020$6.91M 15.0% up
2019$6.01M 1.1% up
2018$5.95M 44.4% down
2017$10.70M 617.6% up
2016$1.49M 93.6% down
2015$23.28M 55.7% up
2014$14.95M 3.3% down
2013$15.47M 9.6% up
2012$14.11M 16.1% down
2011$16.81M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on ABUS

Arbutus Biopharma Corporation, figure by figure

Arbutus Biopharma Corporation (ABUS) overview: price, valuation and scorecard

Arbutus Biopharma Corporation revenue: questions and answers

What is Arbutus Biopharma Corporation's revenue?

Arbutus Biopharma Corporation (ABUS) reported revenue of $14.08M in fiscal 2025 (the year ended December 31, 2025). That is 128.2% higher than the $6.17M of fiscal 2024.

What is the growth rate of Arbutus Biopharma Corporation's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 15.3% a year; over ten years the rate was −4.9% a year.

What are the highest and lowest revenue figures on record for Arbutus Biopharma Corporation?

Across the 15 fiscal years on record (2011–2025), the highest was $39.02M in fiscal 2022 and the lowest $1.49M in fiscal 2016.

How is Arbutus Biopharma Corporation's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Arbutus Biopharma Corporation it is on record here for 15 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arbutus Biopharma Corporation (ABUS) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ABUS/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.